Fei Cao
Chief Executive Officer at HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.
Net worth: 288 223 $ as of 2024-03-30
Profile
Fei Cao has held positions at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Jumpcan Pharmaceutical Co. Ltd.
His current job titles include Vice Chairman & General Manager at Hubei Jumpcan Pharmaceutical Co., Ltd.
and Director at Jumpcan Pharmaceutical Co. Ltd.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2022-09-12 | 1,961,500 ( 0.15% ) | 288 223 $ | 2024-03-30 |
Fei Cao active positions
Companies | Position | Start |
---|---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Chief Executive Officer | 2019-12-19 |
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD. | Health Technology |
Private companies | 1 |
---|---|
Jumpcan Pharmaceutical Co. Ltd.
Jumpcan Pharmaceutical Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of Hubei Jumpcan Pharmaceutical Co., Ltd., Jumpcan Pharmaceutical Co. Ltd. is a pharmaceutical company based in Taixing, China. The Chinese company offers a range of products including mouthwash, cough medicine, and pain relief ointments. The CEO of the private company is Long Xiang Cao. Jumpcan Pharmaceutical Co. was acquired by Hubei Jumpcan Pharmaceutical Co., Ltd. from Jiangsu Jichuan Holdings Group Co. Ltd. on December 20, 2013 for $911.88 million. | Health Technology |
- Stock Market
- Insiders
- Fei Cao